A catastrophic failure in European sperm bank screening has resulted in nearly 200 children being born with a deadly cancer-causing gene, with some already dying from the disease.
Story Snapshot
- Nearly 200 European children were conceived with sperm carrying a cancer-causing gene mutation
- Some children have already died from cancer, with 90% of affected children expected to develop the disease
- European Sperm Bank failed to detect the TP53 gene mutation during 17 years of screening
- International regulatory gaps allowed widespread distribution across 14 countries despite national limits
Screening System Catastrophically Failed Families
The European Sperm Bank’s screening protocols completely missed a devastating genetic mutation that has condemned nearly 200 children to a lifetime of cancer risk. A single donor carrying the TP53 gene mutation passed all screening checks in 2005, leading to 17 years of distributing defective genetic material across Europe.
The mutation causes Li Fraumeni syndrome, giving affected individuals a 90% chance of developing cancer during their lifetimes, particularly in childhood.
Up to 20% of this donor’s sperm contained the mutated TP53 gene, meaning any child conceived with affected sperm carries the dangerous mutation in every cell of their body.
Cancer geneticist Clare Turnbull described the diagnosis as “dreadful” and “clearly devastating,” noting the lifelong burden families must now endure. The TP53 gene normally prevents cells from becoming cancerous, making this mutation particularly destructive to human health.
Sperm from donor with cancer-causing gene was used to conceive almost 200 children https://t.co/o8LZs6ua5H
— BBC News (UK) (@BBCNews) December 10, 2025
Children Already Paying Ultimate Price
The human cost of this regulatory failure is already mounting, with multiple children having died from cancer at very young ages.
Edwige Kasper, a cancer geneticist at France’s Rouen University Hospital, revealed that some children have developed two different cancers and died in early childhood. Out of 67 children initially linked to the donor, 23 were discovered to carry the genetic mutation, with 10 already diagnosed with cancer.
The discovery emerged when doctors treating children with cancers linked to sperm donation raised concerns at this year’s European Society of Human Genetics conference.
Freedom of Information requests by journalists across multiple countries revealed the true scope of the disaster, with at least 197 affected children identified. Experts warn that more affected children could be discovered as additional data becomes available from ongoing investigations.
Regulatory Chaos Enabled International Distribution
The absence of international oversight allowed this single donor’s defective sperm to spread unchecked across 14 European countries through 67 fertility clinics. While individual nations maintain domestic limits on donor usage, no international law restricts how many times donor sperm can be used worldwide.
This regulatory gap enabled the European Sperm Bank in Denmark to distribute the contaminated genetic material far beyond what any single country would permit.
The investigation revealed that some national laws were actually breached during this distribution process. In Belgium, where sperm from a single donor should be limited to six families maximum, 53 children were born to 38 different women using sperm from this genetically defective donor.
This case exposes how loose international coordination in reproductive medicine can create catastrophic consequences for families seeking to build their lives through assisted reproduction.
